Abstract
Vascular tumors are distinguished from vascular malformations by the presence of mitosis, or increased endothelial turnover. Vascular tumors can be benign, locally aggressive, or malignant. Infantile hemangiomas, the most prevalent vascular tumor, are largely benign entities, but can be functionally and cosmetically impairing if not treated in a timely manner. This chapter addresses infantile hemangiomas, vascular tumors with serious consequences (Kasabach-Merritt phenomenon and multifocal lymphangioendotheliomatosis with thrombocytopenia), and common benign tumors (pyogenic granulomas and angiofibromas).
Vascular malformations are static lesions present at birth, and are classified based upon the type of blood vessels that are involved, and as simple (one vessel type) or combined (two or more vascular malformations in one lesion). They are typically noted at birth, grow in proportion with the patient, and consist of abnormal vessels; some are associated with other anomalies such as overgrowth or leptomeningeal malformations, which, based upon their location or exam, may prompt additional workup and treatment. For patients with complex or combined vascular malformations, a combination of the above techniques is often used, depending on malformation location, size, and morbidity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dasgupta R, Fishman SJ. ISSVA classification. Semin Pediatr Surg. 2014;23(4):158–61.
Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128–40.
Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–46.
Chan H, McKay C, Adams S, Wargon O. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds. Pediatrics. 2013;131(6):e1739–47.
Bennett ML, Fleischer Jr AB, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol. 2001;137(9):1208–13.
Drolet BA, Trenor 3rd CC, Brandão LR, Chiu YE, Chun RH, Dasgupta R, et al. Consensus-derived practice standards plan for complicated kaposiform hemangioendothelioma. J Pediatr. 2013;163(1):285–91.
Esparza EM, Deutsch G, Stanescu L, Weinberger E, Brandling-Bennett HA, Sidbury R. Multifocal lymphangioendotheliomatosis with thrombocytopenia: phenotypic variant and course with propranolol, corticosteroids, and aminocaproic acid. J Am Acad Dermatol. 2012;67(1):e62–4.
Lee J, Sinno H, Tahiri Y, Gilardino MS. Treatment options for cutaneous pyogenic granulomas: a review. J Plast Reconstr Aesthet Surg. 2011;64(9):1216–20.
Bae-Harboe YS, Geronemus RG. Targeted topical and combination laser surgery for the treatment of angiofibromas. Lasers Surg Med. 2013;45(9):555–7.
Hofbauer GF, Marcollo-Pini A, Corsenca A, Kistler AD, French LE, Wüthrich RP, et al. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis. Br J Dermatol. 2008;159(2):473–5.
Haemel AK, O’Brian AL, Teng JM. Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis. Arch Dermatol. 2010;146(7):715–8.
Anderson RR, Parrish JA. Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med. 1981;1(3):263–76.
Swetman GL, Berk DR, Vasanawala SS, Feinstein JA, Lane AT, Bruckner AL. Sildenafil for severe lymphatic malformations. N Engl J Med. 2012;366(4):384–6.
Margolin JF, Soni HM, Pimpalwar S. Medical therapy for pediatric vascular anomalies. Semin Plast Surg. 2014;28(2):79–86.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lee, D.H., Hawryluk, E.B. (2017). Vascular Disorders and Anomalies. In: Teng, J., Marqueling, A., Benjamin, L. (eds) Therapy in Pediatric Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-43630-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-43630-2_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43628-9
Online ISBN: 978-3-319-43630-2
eBook Packages: MedicineMedicine (R0)